muscle precursor cell (MPC)-based tissue-engineered therapy
Asset
Autologous muscle precursor cell-based tissue-engineered therapy to regenerate sphincter muscle tissue
- Stage
- Phase 2
- Modality
- Cell therapy
- Target
- Stem cell maintenance
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2Female stress urinary incontinence
Phase 2, globenewswire.com, Oct 7, 2026
Stress urinary incontinence
Phase 2, globenewswire.com, Oct 7, 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.